Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for QA Review of Raw Materials – V 2.0

Posted on By

SOP for QA Review of Raw Materials – V 2.0

Procedure for QA Review of Raw Materials

Department Quality Assurance (QA)/Quality Control (QC)/Production
SOP No. SOP/Ointment/081
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a standardized method for the Quality Assurance (QA) review of raw materials used in ointment manufacturing. This ensures compliance with specifications, regulatory requirements, and Good Manufacturing Practices (GMP).

2. Scope

This SOP applies to all personnel in the QA, Quality Control (QC), and Production departments involved in the review, approval, and release of raw materials before use in manufacturing.

3. Responsibilities

  • Quality Assurance (QA) Officer: Conducts the review of raw materials and associated documentation.
  • Quality Control (QC) Analyst: Performs analytical and microbiological testing of raw materials.
  • Warehouse Supervisor: Ensures proper storage and handling of raw materials.
  • Production Manager: Ensures only QA-approved raw materials are used in production.
See also  Ointments: SOP for Particle Size Analysis in Ointments - V 2.0

4. Accountability

The QA and QC Managers are accountable for ensuring that raw material review is conducted as per regulatory requirements and that only compliant materials are approved for use.

5. Procedure

5.1 Raw Material Documentation Review

  • Check the Certificate of Analysis (CoA) from the supplier.
  • Verify batch number, manufacturing date, and expiry date.
  • Ensure compliance with predefined specifications.
  • Review Material Safety
Data Sheet (MSDS) for handling precautions.

5.2 Physical and Chemical Examination

  • Inspect packaging integrity and labeling details.
  • Verify the appearance, color, odor, and texture of raw materials.
  • Ensure that no contamination, leakage, or tampering is observed.

5.3 Quality Control Testing

  • Perform identification tests using analytical methods (e.g., HPLC, FTIR).
  • Check pH, moisture content, and purity levels.
  • Conduct microbiological testing to detect potential contamination.

5.4 Storage and Handling Review

  • Confirm that raw materials are stored as per defined environmental conditions.
  • Ensure segregation of approved, rejected, and quarantined materials.
  • Monitor storage conditions (e.g., temperature, humidity).

5.5 Approval or Rejection

  • If raw materials meet specifications, approve them for use.
  • If materials fail to meet specifications, quarantine them and initiate corrective actions.
  • Document approval or rejection status in the Raw Material Review Log.

5.6 Documentation

  • Record all raw material review data in the QA Review Log.
  • Attach relevant documents, including CoA, MSDS, and test results.
  • QA must sign off on the final approval before raw material release.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • CoA – Certificate of Analysis
  • MSDS – Material Safety Data Sheet

7. Documents

  • Raw Material Review Log (Annexure-1)
  • Raw Material Approval Report (Annexure-2)

8. References

  • WHO GMP Guidelines for Pharmaceutical Manufacturing
  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • USP <1116> – Microbiological Control and Monitoring

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Raw Material Review Log

Date Material Name Batch Number CoA Verified Physical Inspection QC Test Result Final Status Verified By
01/02/2025 White Petrolatum WP-101 Yes Pass Pass Approved QA Officer
02/02/2025 Mineral Oil MO-102 Yes Pass Fail Rejected QA Officer

Annexure-2: Raw Material Approval Report

Date Material Name Batch Number Specification Compliance Result Final Status Approved By
01/02/2025 White Petrolatum WP-101 Meets Spec Pass Approved QA Head
02/02/2025 Mineral Oil MO-102 Does Not Meet Spec Fail Rejected QA Head

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: Top 5 Safety Hazards in Pharmaceutical Manufacturing and How JSAs Can Mitigate Them
Next Post: SOP for Preparation of Formulation Development Reports

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version